An interventional study of Gamified motor-cognitive dual-task training; Other: Routine physiotherapy and Standard single-task balance training in Cerebral Palsy and Spastic, sponsored by Uskudar University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 11 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Uskudar University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 328 studies in Cerebral Palsy with a site in Turkey — 44 open to participants now, 51 under way, none of them phase 3. Cerebral Palsy · Turkey.
Among the 328 studies in Cerebral Palsy with a site in Turkey, this one is the 19th largest by planned enrollment of the 190 interventional ones that give a count, is one of 21 that started in 2026, is one of 178 with no phase, reaches primary completion later than 46 of the 50 other live ones, and was the 328th registered.
1,939 studies on the registry are indexed under Cerebral Palsy; 457 are open to participants now.
Browse Cerebral Palsy studies →44 of the 328 studies in Cerebral Palsy with a site in Turkey are open now. Recruiting first, the newest first:
Istanbul University - Cerrahpasa · Sites in Turkey
Ages 2–7
Diskapi Yildirim Beyazit Education and Research Hospital · Sites in Turkey
Ages 3–18
Bahçeşehir University · Sites in Turkey
Ages 7–16
Yeditepe University · Sites in Turkey
Ages 18–30
Medipol University · Sites in Turkey
Ages 6–15
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 269 Cerebral Palsy studies recruiting now, 27 (10%) set no upper age limit and 234 (87%) stop at 75 or younger; 254 take children under 18; 52 take healthy volunteers.
This study: 11 Years to 17 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
328 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 21 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is above the median of 34 across 1,432 interventional studies indexed under Cerebral Palsy.
Median enrollment 32 across the 190 interventional studies, 63 across the 138 observational. Of the 243 that completed or were terminated, 12 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 328 have an industry lead sponsor. The 10 most frequent:
Uskudar University is the lead sponsor of 173 studies on the registry; 38 are open to participants now.
Uskudar University has 6 studies filed under Cerebral Palsy — fewer than ten, so there is no comparison to draw.
11 of the studies in Cerebral Palsy with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07836517Yeditepe UniversitySensory-Motor Integration Versus Virtual Reality-Based Exercise in Children With Cerebral Palsy | 2026-11 |
| NCT07681947Yeditepe UniversityA Gamified Breathing and Postural Awareness Education Model for Children With Cerebral Palsy | 2026-11-27 |
| NCT06769178Yeditepe UniversityHow Much Virtual Reality Intervention Improve the Balance of Patients With Cerebral Palsy | 2026-12 |
| NCT07622875Ankara Etlik City HospitalTranscutaneous Diaphragmatic Electrical Stimulation and Pulmonary Function in Non-Ambulatory Cerebral Palsy | 2026-12-01 |
| NCT07846917Atılım UniversitySleep Quality, Caregiver Burden, Stress, and Self-Efficacy in Parents of Children With Spastic Diplegic Cerebral Palsy: A Comparison by Night Orthosis Use | 2026-12-20 |
Add all 11 to your calendar (.ics) → With an account.
Among the 328 studies in Cerebral Palsy with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized controlled trial will investigate whether a low-cost gamified motor-cognitive dual-task training program improves balance and exercise enjoyment more than standard single-task balance training in ambulatory children and adolescents with spastic cerebral palsy aged 11-17 years. Sixty participants attending a special education and rehabilitation center will be randomly assigned to one of two groups. Both groups will continue their routine physiotherapy and receive 30-minute balance training sessions twice a week for 12 weeks. The control group will perform standard single-task balance exercises, while the intervention group will perform the same motor tasks combined with simultaneous cognitive tasks (e.g., counting backwards, naming categories, selecting colored targets) delivered in a game format with low-cost equipment (balls, colored tape, cones, steps). Balance (Pediatric Balance Scale), timed up and go performance under single- and dual-task conditions, gross motor function, walking capacity and exercise enjoyment will be assessed at baseline, after 12 weeks and at a 4-week follow-up by an assessor blinded to group allocation.
Background: Balance impairment is a core limitation in children with spastic cerebral palsy (CP). Dual-task training, which combines motor and cognitive tasks, has been shown in meta-analyses to improve balance more than single-task training; however, most programs rely on computer- or virtual-reality-based systems, and the effect of low-cost, device-free gamified dual-task programs on both balance and exercise enjoyment has not been investigated.
Design: Assessor-blinded, two-arm, parallel-group, 1:1 randomized controlled trial with a 12-week intervention and a 4-week follow-up. Participants will be stratified by Gross Motor Function Classification System (GMFCS) level (I-II vs III) and randomized using a computer-generated block randomization list with sequentially numbered, opaque, sealed envelopes prepared by an investigator not involved in treatment or assessment.
Interventions: Both groups will continue routine physiotherapy (2 sessions/week, 40 minutes) at the center and will additionally receive balance training 2 days/week, 30 minutes/session, for 12 weeks. The control group will receive standard single-task balance training (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow and compliant surfaces) with verbal instructions and without concurrent cognitive tasks. The intervention group will perform the same motor tasks combined with simultaneous cognitive tasks (serial subtraction, category naming, letter-number sequencing, stepping or throwing to colored targets according to verbal cues, simple arithmetic) delivered in a game format (colored targets, ball games, points/stars per session, weekly level progression, personal best records). Progression will be applied every 2 weeks along motor (support surface, speed, vision) and, in the intervention group, cognitive (task difficulty) dimensions. All sessions will be delivered by the same physiotherapist according to a written protocol and documented on a session log. No digital devices will be used.
Outcomes: Assessments will be performed at baseline (T0), at the end of the 12-week intervention (T1) and 4 weeks after the end of the intervention (T2) by a second physiotherapist blinded to group allocation. The primary outcome is the Pediatric Balance Scale. Secondary outcomes are the Timed Up and Go test under single- and dual-task (serial subtraction) conditions and the derived dual-task cost, the Gross Motor Function Measure-88 dimensions D and E, the 1-Minute Walk Test and the Physical Activity Enjoyment Scale (PACES-8, Turkish version). All scales have validated Turkish versions.
Sample size: Based on the minimal clinically important difference of the Pediatric Balance Scale in children with CP (approximately 5.8 points, SD approximately 7; effect size d = 0.80), alpha = 0.05 and power = 80%, 26 participants per group are required; allowing for 15% attrition, 30 participants per group (total 60) will be recruited.
Analysis: Intention-to-treat analysis with multiple imputation for missing data. The primary outcome at 12 weeks will be compared between groups by analysis of covariance adjusted for baseline score and GMFCS stratum. Changes across the three time points will be analyzed with linear mixed-effects models including group, time and group × time interaction. Effect sizes (partial eta squared, Cohen d) with 95% confidence intervals will be reported. Significance will be set at p \< 0.05.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Routine physiotherapy (2 sessions/week, 40 min) plus gamified motor-cognitive dual-task balance training, 2 days/week, 30 min/session, for 12 weeks. Motor balance tasks are combined with simultaneous cognitive tasks and delivered in a game format using low-cost equipment.
Behavioral: Gamified motor-cognitive dual-task training; Other: Routine physiotherapy · Behavioral: Standard single-task balance training
Routine physiotherapy (2 sessions/week, 40 min) plus standard single-task balance training, 2 days/week, 30 min/session, for 12 weeks. Same motor tasks as the experimental arm, delivered with verbal instructions and without concurrent cognitive tasks or game elements.
Behavioral: Standard single-task balance training
Balance exercises (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow/compliant surfaces) performed simultaneously with cognitive tasks (serial subtraction by 3s progressing to 7s, category naming, letter-number sequencing, stepping/throwing to colored targets on verbal cue, simple arithmetic). Delivered in a game format: colored floor and wall targets, ball catching/throwing and target games, points/stars per session, weekly level progression and personal best records. Progression every 2 weeks on motor (support surface, speed, vision) and cognitive (task difficulty) dimensions. Equipment: balls, colored tape, cones, steps; no digital devices. 2 days/week × 30 min × 12 weeks, delivered one-to-one by a physiotherapist.
The same balance exercises (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow/compliant surfaces) performed with verbal instructions only, without concurrent cognitive tasks or game elements. Progression every 2 weeks on support surface, speed and vision. 2 days/week × 30 min × 12 weeks, delivered one-to-one by a physiotherapist.
Pediatric Balance Scale (PBS) score at 12 weeks
The PBS is a 14-item functional balance scale for children, each item scored 0-4; total score 0-56, higher scores indicate better balance. Turkish version validated in children with cerebral palsy.
Time frame: Week 12 (end of intervention)
Change in Pediatric Balance Scale (PBS) score
Same scale as the primary outcome; change from baseline.
Time frame: Baseline, Week 12, Week 16 (4-week follow-up)
Timed Up and Go (TUG) test - single task
Time (seconds) to stand from a chair, walk 3 m, turn, return and sit; mean of three trials. Lower values indicate better functional mobility.
Time frame: Baseline, Week 12, Week 16
Gross Motor Function Measure-88 (GMFM-88), Dimension D (standing)
13 items scored 0-3; dimension percentage score 0-100, higher scores indicate better gross motor function. Turkish version validated.
Time frame: Baseline, Week 12, Week 16
1-Minute Walk Test (1MWT)
Distance (meters) walked in 1 minute at a comfortable pace; higher values indicate better walking capacity.
Time frame: Baseline, Week 12, Week 16
Physical Activity Enjoyment Scale (PACES-8, Turkish version)
8 items rated on a 7-point Likert scale; total score 8-56, higher scores indicate greater enjoyment of physical activity.
Time frame: Baseline, Week 12, Week 16
Plan to share: Undecided — De-identified individual participant data may be made available from the principal investigator upon reasonable request after publication of the main results.
Start is estimated for Dec 2026; primary completion for Feb 2027, 2 months later.
Of 903 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 2 months is below that.
Counting every sponsor, half of 922 studies reached it within 12 months; a quarter within 5 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.